The efficiency of feedstuff utilization by ruminal microorganisms and the cow\u27s genetic ability to convert feed nutrients into milk and milk components are major factors that influence the profitability of a dairy herd. Monensin\u27s ability to modify the movement of ions across biological membranes leads to alterations in bacterial populations and subsequent changes in the proportion of volatile fatty acids produced during ruminal fermentation. Manipulating ruminal microbial populations with ionophores has the potential to improve performance by reducing ketosis, acidosis, and bloat and increasing digestive efficiency. Monensin improves fiber digestion by preventing suboptimal ruminal pH, enhances amino acid use by reducing the degradat...
Since the approval by the European Medicines Agency in 2013 of a monensin controlled-release capsule...
The mechanisms behind the metabolic changes observed when transition cows are administered monensin,...
Since the approval by the European Medicines Agency in 2013 of a monensin controlled-release capsule...
The efficiency of feedstuff utilization by ruminal microorganisms and the cow’s genetic ability to...
Thirty-two Holstein transition cows were used to determine the effects of monensin (Rumensin, Elanco...
Monensin is a carboxylic polyether ionophore producedby a naturally occurring strain of Streptomyc...
This study determined effects of adding sodium monensin, the active ingredient in Rumensin 90TM, to ...
Doctor of PhilosophyDepartment of Animal Sciences and IndustryBarry J. BradfordThe mechanisms behind...
Twenty Holstein-Friesian cows, two to four months postpartum, were randomly assigned to two groups. ...
Four primiparous Holstein cows were gradually introduced, according to a Latin square design, to fou...
To identify differences in rumen function as a result of feeding monensin to beef cattle, rumen flui...
Four primiparous Holstein cows were gradually introduced, according to a Latin square design, to fou...
The effect of Monensin on clinical mastitis in dairy cattle was evaluated from data collected at nin...
Effects of the administration of monensin via concentrates to dairy cows were studied in two trials....
AbstractThe effects of monensin on transition cow metabolism may be dependent on modulation of feedi...
Since the approval by the European Medicines Agency in 2013 of a monensin controlled-release capsule...
The mechanisms behind the metabolic changes observed when transition cows are administered monensin,...
Since the approval by the European Medicines Agency in 2013 of a monensin controlled-release capsule...
The efficiency of feedstuff utilization by ruminal microorganisms and the cow’s genetic ability to...
Thirty-two Holstein transition cows were used to determine the effects of monensin (Rumensin, Elanco...
Monensin is a carboxylic polyether ionophore producedby a naturally occurring strain of Streptomyc...
This study determined effects of adding sodium monensin, the active ingredient in Rumensin 90TM, to ...
Doctor of PhilosophyDepartment of Animal Sciences and IndustryBarry J. BradfordThe mechanisms behind...
Twenty Holstein-Friesian cows, two to four months postpartum, were randomly assigned to two groups. ...
Four primiparous Holstein cows were gradually introduced, according to a Latin square design, to fou...
To identify differences in rumen function as a result of feeding monensin to beef cattle, rumen flui...
Four primiparous Holstein cows were gradually introduced, according to a Latin square design, to fou...
The effect of Monensin on clinical mastitis in dairy cattle was evaluated from data collected at nin...
Effects of the administration of monensin via concentrates to dairy cows were studied in two trials....
AbstractThe effects of monensin on transition cow metabolism may be dependent on modulation of feedi...
Since the approval by the European Medicines Agency in 2013 of a monensin controlled-release capsule...
The mechanisms behind the metabolic changes observed when transition cows are administered monensin,...
Since the approval by the European Medicines Agency in 2013 of a monensin controlled-release capsule...